| scholarly article | Q13442814 |
| P2093 | author name string | Meyer J | |
| Hafner G | |||
| Heimann A | |||
| Kempski O | |||
| Petersen S | |||
| Bhakdi S | |||
| Darius H | |||
| Loos M | |||
| Götze O | |||
| Berg O | |||
| Horstick G | |||
| Bierbach B | |||
| Horstick M | |||
| P433 | issue | 25 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3125-3131 | |
| P577 | publication date | 2001-12-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Application of C1-esterase inhibitor during reperfusion of ischemic myocardium: dose-related beneficial versus detrimental effects | |
| P478 | volume | 104 |
| Q38126385 | Anti-inflammatory strategies to enhance islet engraftment and survival |
| Q38206175 | Antibody-mediated rejection in kidney transplantation: a review of pathophysiology, diagnosis, and treatment options |
| Q28972362 | BIOLOGICAL ACTIVITIES OF C1 INHIBITOR |
| Q35567084 | Bench-to-bedside review: the role of C1-esterase inhibitor in sepsis and other critical illnesses |
| Q36838407 | C1 inhibitor: biologic activities that are independent of protease inhibition |
| Q34464961 | C1 inhibitor: molecular and clinical aspects |
| Q87523826 | C1-esterase inhibitor treatment: preclinical safety aspects on the potential prothrombotic risk |
| Q35683784 | Cinryze as the first approved C1 inhibitor in the USA for the treatment of hereditary angioedema: approval, efficacy and safety |
| Q55262251 | Complement Activation During Ischemia/Reperfusion Injury Induces Pericyte-to-Myofibroblast Transdifferentiation Regulating Peritubular Capillary Lumen Reduction Through pERK Signaling. |
| Q36269099 | Complement activation and cardiac surgery: a novel target for improving outcomes |
| Q36405114 | Complement activity and pharmacological inhibition in cardiovascular disease |
| Q35053536 | Complement in ischemia reperfusion injury |
| Q43055050 | Effect of a lung recruitment maneuver by high-frequency oscillatory ventilation in experimental acute lung injury on organ blood flow in pigs |
| Q52948580 | Effects of C1 esterase inhibitor administration on intestinal functional capillary density, leukocyte adherence and mesenteric plasma extravasation during experimental endotoxemia. |
| Q35535831 | Elevated D-dimers in attacks of hereditary angioedema are not associated with increased thrombotic risk. |
| Q28577389 | Inhibition of classical complement activation attenuates liver ischaemia and reperfusion injury in a rat model |
| Q37280720 | Inhibition of complement improves graft outcome in a pig model of kidney autotransplantation |
| Q38233524 | Liver ischemia/reperfusion injury: an overview |
| Q33616097 | Mannan-binding lectin in cardiovascular disease |
| Q58143875 | Meconium Is a Potent Activator of Complement in Human Serum and in Piglets |
| Q51279830 | Mouse cardiac surgery: comprehensive techniques for the generation of mouse models of human diseases and their application for genomic studies. |
| Q53106505 | Myocardial infarction induces atrial inflammation that can be prevented by C1-esterase inhibitor. |
| Q36960513 | Natural IgM-mediated innate autoimmunity: a new target for early intervention of ischemia-reperfusion injury |
| Q41821623 | Nebulized C1-Esterase Inhibitor does not Reduce Pulmonary Complement Activation in Rats with Severe Streptococcus Pneumoniae Pneumonia. |
| Q38799021 | On the value of therapeutic interventions targeting the complement system in acute myocardial infarction |
| Q37831329 | Role of complement and perspectives for intervention in ischemia-reperfusion damage. |
| Q34263683 | Role of the complement system in rejection. |
| Q42152131 | The Emerging Role of TLR and Innate Immunity in Cardiovascular Disease |
| Q55106013 | The Lectin Pathway of Complement in Myocardial Ischemia/Reperfusion Injury—Review of Its Significance and the Potential Impact of Therapeutic Interference by C1 Esterase Inhibitor. |
| Q35671717 | The biological role of the C1 inhibitor in regulation of vascular permeability and modulation of inflammation |
| Q38042217 | The complement system in ischemia-reperfusion injuries |
| Q36253316 | The effect of C1 inhibitor on myocardial ischemia and reperfusion injury |
Search more.